About
Albireo Pharma, Inc. is a biopharmaceutical company developing therapies for rare pediatric and adult cholestatic liver diseases, including odevixibat (Bylvay), an approved oral ileal bile acid transporter inhibitor for specific rare cholestatic conditions.
Explore Albireo Pharma, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.